BackBruker Overview
Bruker Corp

Bruker Target Price

See Bruker's analyst price targets ($54) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$56.85

Average Target Price

$53.835.3% downside

6 analysts in the last 4 months

High: $70 | Low: $45

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-05Stifel Nicolaus$5012% downsideOpen
2026-06-29GuggenheimSubbu Nambi$7023.1% upsideOpen
2026-06-24UBS$605.5% upsideOpen
2026-05-08Stifel NicolausDaniel Arias$4520.8% downsideOpen
2026-05-07UBS$4520.8% downsideOpen
2026-05-07BarclaysLuke Sergott$536.8% downsideOpen
2026-02-13Goldman SachsEvie Koslosky$3538.4% downsideOpen
2026-02-13UBS$4913.8% downsideOpen
2026-02-13BarclaysLuke Sergott$5012% downsideOpen
2026-02-12Jefferies$5012% downsideOpen
2026-01-26Guggenheim$582% upsideOpen
2026-01-05GuggenheimSubbu Nambi$536.8% downsideOpen
2025-12-15Wells FargoBrandon Couillard$553.3% downsideOpen
2025-12-15Barclays$553.3% downsideOpen
2025-12-10Wolfe Research$605.5% upsideOpen
2025-12-09Goldman Sachs$4029.6% downsideOpen
2025-11-20Redburn Partners$605.5% upsideOpen
2025-11-04UBS$4324.4% downsideOpen
2025-11-04Barclays$4520.8% downsideOpen
2025-10-02Barclays$4029.6% downsideOpen
2025-08-05Stifel NicolausDaniel Arias$4029.6% downsideOpen
2025-08-04BarclaysLuke Sergott$4324.4% downsideOpen
2025-08-04Jefferies$605.5% upsideOpen
2024-12-19GuggenheimSubbu Nambi$7226.6% upsideOpen
2024-09-23CitigroupPatrick Donnelly$8040.7% upsideOpen
2024-08-27Wells FargoBrandon Couillard$7837.2% upsideOpen
2024-05-20Stifel NicolausDaniel Arias$7735.4% upsideOpen
2021-05-05J.P. MorganTycho Peterson$605.5% upsideOpen

Bruker (BRKR) FAQ

As of the most recent data, BRKR shows a target price of $54. Scroll down for historical charts and peer comparison views.

If Bruker moved to the average analyst target of $54, shares would be roughly 5.3% lower than $56.85. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Bruker's earnings trajectory.

Besides this target price page, Stockcircle has Bruker's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $54) with ownership activity and broader fundamentals.

Bruker's target price is $54; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.